Larvol Delta - In-Vivo-Identification-of-Adducts-from-the-New-HypoxiaActivated-Prodrug-CP506-Using-DNA-Adductomics

CP-506 - Convert Pharma

http://www.ncbi.nlm.nih.gov/pubmed/35050609

Jan 21, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next